Arena Pharmaceuticals, Inc. (ARNA) Posts Q3 Loss of 16c/Sh.

Article Stock Quotes (1) Comments (0)

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q3 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $3.46 million versus the consensus estimate of $3.37 million.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
• Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
• Childrens Place (PLCE) Tops Q1 EPS by 22c; Boosts Outlook

Create E-mail Alert Related Categories

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?